16-18
Jun
2026
CPHI & PMEC China 2026
Shanghai New International Expo Center
E3D02
6-8
Oct
2026
CPHI Milan 2026
Fiera Milano, Italy
1A94
23-25
Nov
2026
CPHI India 2026
IICC, Yashobhoomi, Dwarka, Delhi
2A45
14-16
Dec
2026
CPHI Middle East 2026
Riyadh Exhibition and Convention Centre, Malham, Saudi Arabia
H2.G54

Boai NKY Pharmaceuticals Ltd

About Boai NKY Pharmaceuticals Ltd

Boai NKY Pharmaceuticals Ltd (NKY, stock code: 300109) is publicly traded company on the Shenzhen stock exchange, the first domestic company to develop and manufacture PVP and PVM/MA products, the 3rd largest Global PVP manufacturer; Our product, KoVidone® and PolyKoVidone® line of products representing Povidone, Crospovidone and Copovidone pharmaceutical excipients. KoVidone®-I (PVP-I) broad spectrum biocidal, antifungal and antiviral agent. OraRez® line of PVM/MA Copolymer and derivatives respresenting functional polymers for bioadhesive/mucoadhesive applications. Pharmaceutical solvents and intermediates; NKY is the first Chinese manufacturer to be EXCiPACTTM GMP certifie...

Meet us at

  • CPHI & PMEC China 2026

    Shanghai New International Expo Center
    16 Jun 2026 - 18 Jun 2026
  • CPHI Milan 2026

    Fiera Milano, Italy
    6 Oct 2026 - 8 Oct 2026
  • CPHI India 2026

    IICC, Yashobhoomi, Dwarka, Delhi
    23 Nov 2026 - 25 Nov 2026
  • CPHI Middle East 2026

    Riyadh Exhibition and Convention Centre, Malham, Saudi Arabia
    14 Dec 2026 - 16 Dec 2026
  • Country/Region:
    China
  • On CPHI since:
    2015
Contact info

Products from Boai NKY Pharmaceuticals Ltd (5)

Boai NKY Pharmaceuticals Ltd Resources (1)